Pharaoh Neuro, Inc.
PrivateLast Round
Series A
Feb 18, 2026
Total Funding Raised
$20M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pharaoh Neuro, Inc. is a medical device company that develops innovative solutions for neurocritical care, including its Neurapheresis™ cerebrospinal fluid management system.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharaoh Neuro, Inc. Comparables
Compare Pharaoh Neuro, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Minnetronix Medical | 85% | |
| BrainSpace | 84% | |
| EnClear Therapies | 78% |
Pharaoh Neuro, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 18, 2026 |
Key People
Founding team and executive leadership
Pharaoh Neuro, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arboretum Ventures | Series A |
| IAG Capital Partners | Series A |
| Hatteras Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 28, 2026
Grew 50% QoQ from 8 to 12 employees.
- May 15, 2026
Monthly visitors grew 57% MoM.
Recent news
Latest coverage and updates
- hiresJul 27, 2026
Pharaoh Neuro, Inc. hired Mike Blue as board of directors on Jul 27th '26.
Pharaoh Neuro, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access